Today, we want to share our analysis of Agenus ( AGEN ) with you. Over the last year, its stock fluctuated largely, falling from ~$3.67 in January 2019 to ~$2.6 in August 2019. Recently, the company’s stock price grew by over 15%, driven by the IND acceptance for AGEN2373. The company...

Agenus, Inc. (AGEN) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Jennifer Buell – Chief Operating Officer Garo Armen – Chairman and Chief Executive Officer Paisley Myers – Senior Scientist Christine Klaskin – Vice P...

Agenus ( AGEN +8% ) is up on light volume in early trade on the heels of its announcement  that the FDA has accepted its IND filing for immuno-oncology (I-O) candidate AGEN2373, triggering a $7.5M milestone payment from collaboration partner Gilead Sciences ( GILD ). More news on: ...